References
- Metzger B E, Coustan D R. The Organizing Committee: summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998; 21(Suppl 2)B161–B167
- Sepe S J, Connell F A, Geiss L S, Teutsch S M. Gestational diabetes: incidence, maternal characteristics, and perinatal outcome. Diabetes 1985; 34(Suppl 2)13–16
- Weeks J W, Major C A, de Veciana M, Morgan M A. Gestational diabetes: does the presence of risk factors influence perinatal outcome?. Am J Obstet Gynecol 1994; 171: 1003–1007
- Homko C J, Sivan E, Reece E A, Boden G. Fuel metabolism during pregnancy. Semin Reprod Endocrinol 1999; 17: 119–125
- Linne Y, Barkeling B, Rossner S. Natural course of gestational diabetes mellitus: long term follow up of women in the SPAWN study. BJOG 2002; 109: 1227–1231
- Kjos S I, Peters R K, Xiang A, Henry O A, Montoro M, Buchanan T A. Predicting future diabetes in Latino women with gestational diabetes: utility of the early postpartum glucose tolerance testing. Diabetes 1995; 44: 586–591
- Díez J J, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148: 293–300
- Havel P J. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004; 53(Suppl 1)S143–S151
- Arita Y, Kihara S, Ouchi N. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Comm 2000; 257: 79–83
- American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004; 27: S88–S90
- Jovanovic L. American Diabetes Association's Fourth International Workshop-Conference on Gestational Diabetes Mellitus: summary and discussion. Therapeutic intervention. Diabetes Care 1998; 21(Suppl 2)B131–137
- Maghbooli Z H, Hossein-nezhad A, Karimi F, Shafaei A R, Larijani B. Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev 2008; 24: 27–32
- Tsai P J, Yu C H, Hsu S P, Lee Y H, Huang I T, Ho S C, Chu C H. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus. Nutrition 2005; 21: 1095–1099
- Worda C, Leipold H, Gruber Ch, Kautzky-Willer A, Knöfler M, Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 2004; 191: 2120–2124
- Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley R E, Tataranni P A. Hypoadiponectimia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Clin Endocrinol Metab J 2001; 86: 1930–1935
- Kjos S L, Buchanan T A. Gestational diabetes mellitus. N Engl J Med 1999; 341: 1749–1756
- Retnakaran R, Hanley A JG, Raif N, Hirning C R, Connelly P W, Sermer M, Kahn S E, Zinman B. Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 2005; 48: 993–1001
- Retnakaran R, Hanley A JG, Raif N, Hirning C R, Connelly P W, Sermer M, Kahn S E, Zinman B. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 2004; 27: 799–800
- Vitoratos N, Deliveliotou A, Vlahos N, Mastorakos G, Papadias K, Botsis D, Creatsas G K. Serum adiponectin during pregnancy and post partum in women with gestational diabetes and normal control. Gynecol Endocrinol 2008; 24: 614–619
- Cseh K, Baranyl E, Melczer Z. Plasma adiponectin and pregnancy induced insulin resistance. Diabetes Care 2004; 27: 274–275
- Chan T F, Yuan S S, Chen H S, Guu C F, Wu L C, Yeh Y T, Chung Y F, Jong S B, Su J H. Correlations between umbilical and maternal serum adiponectin levels and neonatal birthweights. Acta Obstet Gynecol Scand 2004; 83: 165–169